Lilia arrive au CHU d’Angers

We are pleased to announce the launch of Lilia's study at Angers University Hospital, coordinated by Professor Cédric Annweiler and the Center for Research on Autonomy and Longevity (CeRAL). This multicenter study evaluates the effects of personalized reminiscence sessions delivered by Kompanion Care, a digital conversational companion based on artificial intelligence, on people with mild neurocognitive disorder or early dementia.

Each participant benefits from daily 10- to 15-minute sessions, tailored to their personal story and enriched by biographical content shared by their loved ones. The goal is to explore whether these digital interactions can promote cognitive stimulation, emotional balance, and quality of life, while reducing the burden on caregivers.

Why This Matters:

• Exploring new non-pharmacological avenues to support people living with mild cognitive decline, at a time when curative treatments remain limited.

• Valuing memory and emotions as therapeutic levers thanks to digital, personalized and interactive reminiscence.

• Strengthening social and family ties, by involving relatives in the co-construction of biographical content.

• Testing the clinical relevance of empathic technologies, able to adapt their exchanges to each patient for more human support.

  
  

👉 Discover how Lilia supports brain health

Professor Cédric Annweiler

Head of the PARADH division 

Head of CeRAL – Angers University Hospital

⭐⭐⭐⭐⭐

"We are participating with interest in the clinical evaluation of Lilia as part of the CeRAL at the Angers University Hospital. This study aims to explore the extent to which a digital conversational agent, based on reminiscence and the personalization of exchanges, could contribute to the cognitive and emotional well-being of people with mild neurocognitive disorders.Beyond the technology itself, this project questions our ability to harness artificial intelligence to enhance relationships, memory, and quality of life. Initial feedback from patients and teams is encouraging, but ongoing scientific evaluation remains essential to assess the true effectiveness and place of empathic technologies in the range of non-pharmacological interventions."

Stay tuned for more stories from the frontlines of dementia care innovation.